ERNA
Price
$1.79
Change
-$0.12 (-6.28%)
Updated
Jul 29 closing price
Capitalization
13.18M
NMRA
Price
$2.19
Change
-$0.09 (-3.95%)
Updated
Jul 29 closing price
Capitalization
353.42M
7 days until earnings call
Interact to see
Advertisement

ERNA vs NMRA

Header iconERNA vs NMRA Comparison
Open Charts ERNA vs NMRABanner chart's image
Ernexa Therapeutics
Price$1.79
Change-$0.12 (-6.28%)
Volume$25.87K
Capitalization13.18M
Neumora Therapeutics
Price$2.19
Change-$0.09 (-3.95%)
Volume$1.84M
Capitalization353.42M
ERNA vs NMRA Comparison Chart in %
Loading...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERNA vs. NMRA commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERNA is a Buy and NMRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (ERNA: $1.79 vs. NMRA: $2.19)
Brand notoriety: ERNA and NMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERNA: 26% vs. NMRA: 108%
Market capitalization -- ERNA: $13.18M vs. NMRA: $353.42M
ERNA [@Biotechnology] is valued at $13.18M. NMRA’s [@Biotechnology] market capitalization is $353.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERNA’s FA Score shows that 0 FA rating(s) are green whileNMRA’s FA Score has 1 green FA rating(s).

  • ERNA’s FA Score: 0 green, 5 red.
  • NMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, NMRA is a better buy in the long-term than ERNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERNA’s TA Score shows that 5 TA indicator(s) are bullish while NMRA’s TA Score has 5 bullish TA indicator(s).

  • ERNA’s TA Score: 5 bullish, 3 bearish.
  • NMRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ERNA is a better buy in the short-term than NMRA.

Price Growth

ERNA (@Biotechnology) experienced а -10.95% price change this week, while NMRA (@Biotechnology) price change was +15.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +44.56%.

Reported Earning Dates

NMRA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMRA($353M) has a higher market cap than ERNA($13.2M). ERNA YTD gains are higher at: -59.410 vs. NMRA (-79.340). NMRA has more cash in the bank: 249M vs. ERNA (1.92M). NMRA has less debt than ERNA: NMRA (938K) vs ERNA (2.88M).
ERNANMRAERNA / NMRA
Capitalization13.2M353M4%
EBITDAN/A-273.7M-
Gain YTD-59.410-79.34075%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash1.92M249M1%
Total Debt2.88M938K307%
FUNDAMENTALS RATINGS
ERNA: Fundamental Ratings
ERNA
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERNANMRA
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KREF9.250.07
+0.76%
KKR Real Estate Finance Trust
ILMN108.71-1.17
-1.06%
Illumina
KYMR43.70-0.50
-1.13%
Kymera Therapeutics
AIRI3.44-0.05
-1.43%
Air Industries Group
CWBC19.99-0.32
-1.58%
Community West Bancshares

ERNA and

Correlation & Price change

A.I.dvisor tells us that ERNA and ATOS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERNA and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERNA
1D Price
Change %
ERNA100%
-6.28%
ATOS - ERNA
28%
Poorly correlated
+13.14%
RNTX - ERNA
27%
Poorly correlated
-11.35%
VSTM - ERNA
25%
Poorly correlated
+4.49%
RAIN - ERNA
25%
Poorly correlated
+1.07%
NMRA - ERNA
25%
Poorly correlated
-3.95%
More

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with NGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
-3.95%
NGNE - NMRA
38%
Loosely correlated
-3.14%
ABOS - NMRA
37%
Loosely correlated
-5.48%
AURA - NMRA
36%
Loosely correlated
-2.86%
SNDX - NMRA
35%
Loosely correlated
+8.15%
RCUS - NMRA
34%
Loosely correlated
-2.44%
More